Science + Technology

Cannabis science and technology connects researchers, scientists, business and entrepreneurs. Learn recommended quality standards across the cannabis industry supply chain to improve efficiencies centered on providing affordable cannabis therapeutics and to provide quality patient care.



Beyond Limits: SOBEREYE’s Vision for Modernizing Workplace Impairment Testing


As more and more U.S. states legalize medical and/or adult-use cannabis, employers must balance several competing requirements. They are understandably concerned about cannabis use and on-the-job safety. Workplace accidents are expensive with the average employer spending about $120,000 on every workplace injury incident. Along with the financial toll, businesses face reputational damage, lower productivity, and, most importantly, the human cost of lives damaged or lost. Enter the burgeoning industry of impairment detection technologies (IDTs) for impairment detection for chemical factors, such as legal or illegal substances; physical factors including fatigue; and psychosocial factors, i.e., stress.

The National Safety Council defines impairment: “The inability to function normally or safely because of any number of critical factors—from chemical factors such as legal and illicit drugs, physical factors such as fatigue or certain mental conditions, as well as social factors like stress, or other mental distress. Each of these factors and more can present a fitness for duty, concern and impact, employee health, safety, and well-being.”

To meet the growing demand for workplace solutions, there’s a burgeoning industry of impairment detection devices (IDTs) like cognitive testing apps, brain-imaging caps (in development), and full-body scans aim to flag compromised faculties before any damage is done, but not all high-tech solutions are portable, cost-effective, or intuitive for employees to use. One ingenious and user-friendly IDT is SOBEREYE, an AI-driven startup from California, which measures the Pupillary Light Reflex (PLR), an autonomic response of the eye to bright light that indicates nominal function of both the somatic processing (incoming signals from the periphery) and the central nervous system response.

SOBEREYE patented its approach utilizing a smartphone and an opaque enclosure to make accurate PLR measurements to detect impairment. Everyone in the workplace shares the same goal: to get work done safely. The years invested in developing SOBEREYE's technology are justified by the profound impact of saving even a single life.

Download Beyond Limits: SOBEREYE’s Vision for Modernizing Workplace Impairment Testing

The tumbleweed of grief

Treating Grief + Medical Cannabis

Grief is a multifaceted emotional response to loss, manifesting uniquely in each individual and often unpredictably over time. Its symptoms can range widely, from...

Cannabis Product Testing: Pass or Fail?

In any industry, third-party or independent lab testing provides validation for the manufacturer’s safety and label claims on any product intended for consumption. The...

Formulation Considerations for Asthma Treatment with CBD MDI

CBD delivered by a MDI is an efficacious treatment for asthma. Formulation for the product requires specific considerations.

Chronic Pain: Transdermal Cannabinoid v Opioid Therapy

Pain control is the most common use for medical cannabis in the United States. While cannabis isn’t strong enough for severe pain, e.g. post-surgical pain or...

The Future of Medical Cannabis Includes Pharma

The future of medical cannabis is quite promising yet requires the leveraging of best practices and knowledge assets of the following industries: cannabis, technology,...